🔗 Share this article

Chancellor Rachel Reeves has announced she is preparing "specific action to tackle cost of living issues" in the forthcoming financial statement.

Speaking to media outlets, she stated that curbing inflation is a shared duty of both the administration and the Bank of England.

The United Kingdom's price growth is expected to be the most elevated among the Group of Seven industrialized countries this year and the following year.

Possible Energy Cost Interventions

Reports indicate the administration could intervene to lower energy bills, for example by slashing the current 5% rate of VAT charged on energy supplies.

Another approach is to reduce some of the government charges currently added to household expenses.

Fiscal Constraints and Analyst Predictions

The administration will obtain the latest draft from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much scope there is for these actions.

The expectation from most experts is that the Chancellor will have to introduce tax rises or spending cuts in order to meet her declared borrowing rules.

Previously on Thursday, calculations suggested there was a £22 billion shortfall for the chancellor to fill, which is at the lower end of forecasts.

"It is a collective job between the Bank of England and the administration to bear down further on some of the causes of inflation," Reeves told reporters in the US capital, at the yearly gatherings of the International Monetary Fund and World Bank.

Revenue Commitments and Global Issues

While much of the focus has been on expected tax increases, the Treasury chief said the latest information from the OBR had not changed her pledge to election pledges not to raise rates on income tax, VAT or National Insurance.

She attributed an "unpredictable global environment" with increasing geopolitical and commercial tensions for the fiscal revenue measures, likely to be focused on those "with the broadest shoulders."

Global Economic Tensions

Commenting on worries about the United Kingdom's economic relations with the Asian nation she said: "Our national security always come first."

Recent announcement by Chinese authorities to strengthen trade restrictions on rare earths and other materials that are crucial for advanced tech production led US President Donald Trump to suggest an extra 100% tariff on imports from the Asian country, increasing the possibility of an all-out commercial conflict between the two global powers.

The US Treasury Secretary labeled the Chinese move "commercial pressure" and "a global supply chain control attempt."

Inquired about considering the American proposal to join its dispute with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and urged the Chinese government "not to put up barriers and limit trade."

She said the decision was "damaging for the global economy and causes further obstacles."

"It is my opinion there are sectors where we must address Chinese policies, but there are also valuable opportunities to trade with China's economy, including financial services and other areas of the economic system. We've got to maintain that balance appropriate."

The Treasury chief also stated she was cooperating with G7 counterparts "regarding our own essential resources approach, so that we are reduced dependence."

Health Service Drug Costs and Investment

Reeves also acknowledged that the price the National Health Service spends on pharmaceuticals could rise as a result of ongoing talks with the US government and its pharmaceutical firms, in return for lower tariffs and funding.

A number of the biggest global drug companies have said lately that they are either delaying or canceling operations in the UK, with some attributing the insufficient payments they are getting.

Recently, the government science advisor said the cost the NHS pays for medicines would have to increase to halt companies and drug research funding leaving the UK.

Reeves told media: "We have seen due to the pricing regime, that drug testing, innovative medicines have not been available in the United Kingdom in the extent that they are in other continental states."

"We want to make sure that individuals getting care from the National Health Service are able to access the top critical treatments in the world. And so we are looking at these issues, and... aiming to obtain increased investment into Britain."